Journal Article Alternative to Rituximab Therapy for a Patient with Ankylosing Spondylitis Who Was Unable to Continue Anti-TNF Therapy

Katsuyama, Eri  ,  Wakabayashi, Hiroshi  ,  Sada, Ken-ei  ,  Hiramatsu, Sumie  ,  Miyawaki, Yoshia  ,  Morishita, Michiko  ,  Ohashi, Keiji  ,  Watanabe, Haruki  ,  Katsuyama, Takayuki  ,  Zeggar, Sonia  ,  Narazaki, Mariko  ,  Tatebe, Noriko  ,  Watanabe, Katsue S.  ,  Kawabata, Tomoko  ,  Wada, Jun

71 ( 5 )  , pp.445 - 448 , 2017-10 , Okayama University Medical School
We herein present a case of a 38-year-old man who had bamboo spine and severe sacroiliitis and who was diagnosed with ankylosing spondylitis (AS). Infliximab (IFX) markedly improved the axial symptom but was discontinued due to the side effect of peripheral neuropathy. Switching from IFX to etanercept worsened the side effect. Rituximab (RTX) administration elicited a good response without side effects. RTX might be a suitable option for AS therapy when TNF inhibitors are difficult to use.

Number of accesses :  

Other information